contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


novonesis-issues-eur-17-billion-in-bonds-to-refinance-bridge-facility

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Novonesis är verksamma inom biokemi. Bolaget utvecklar enzymer och mikroorganismer för industriellt bruk. Enzymerna är ett protein som används inom ett flertal olika branscher, huvudsakligen inom jordbruks- och livsmedelsindustrin. Produkterna används inom livsmedel samt kläder, och försäljning innehas på global nivå, med störst närvaro inom Norden och Europa. Bolaget har sitt huvudkontor i Bagsværd.

Novonesis

COPENHAGEN, Denmark – March 16, 2026. Novonesis has completed a EUR 1.7 billion bond issuance, with significant interest from a broad group of investors. The transaction was primarily undertaken...

COPENHAGEN, Denmark – March 16, 2026. Novonesis has completed a EUR 1.7 billion bond issuance, with significant interest from a broad group of investors. The transaction was primarily undertaken to refinance the bridge facility related to Novonesis’ purchase of the dsm firmenich’s part in the Feed Enzyme Alliance, closed in June 2025. The acquisition gives Novonesis full control of the alliance’s sales and distribution, strengthening the company’s position across the animal biosolutions value chain. Rainer Lehmann, CFO:&nbsp; “The significant interest from investors reflects confidence in Novonesis, our business model and the strategic direction we have set for the company. We remain well-positioned to capture growth opportunities in the years ahead." &nbsp; Transaction details Novonesis, through Novozymes A/S, has successfully priced and closed an aggregate principal amount of EUR 1.7 billion senior unsecured notes (the “Notes”). The issuance was completed under the company’s newly established EUR 4 billion Euro Medium Term Note (EMTN) Program. The Notes will be issued on March 19, 2026, and listed on the Luxembourg Stock Exchange. This inaugural issuance consists of three tranches with maturities ranging from 4 to 11 years and fixed interest rates ranging from 3.25% to 4.00%. The Notes have been rated in line with the company’s corporate credit rating of A &nbsp;with a stable outlook. Read the company announcement here: <a href="https://www.globenewswire.com/Tracker?data=XpuoXvxOQWPVMj8dTbf8KjG92PPM_u-liEAQoUXFdYTk8CzsEoktT6iZ6AXHcWnAuGW5cLYD8ZN35Yhy8WQRBo17v7KPF4290x8JU-OwVlvk3Xd0cVr22oT1YipjNsBbfO0NapKm-wSqJ-ibXmMY0XSE-4E7Cu873XYkpjkHKW-nD6h-eQrnu8fg7byMatOPZts3FdxpRQANSQTxIDAu3FR-GJ2j4mvwQjpNgY0jFzt_FLbm2vZaxyvDkoNXHj9w_oX29ksiWHNJFpsMX11kinvauDuT3nmVanUATWpH46KluYdp42q3uHusdfVNwrBEm_MmBkZbW-SBhs4iBcOaa_4363b7bj9zew-RWlHYLPQ=">https://tools.eurolandir.com/tools/Pressreleases/GetPressRelease/?ID=7917784&amp;lang=en-GB&amp;companycode=dk-nzmb&amp;v=r2024</a> &nbsp; Get in touch Line Emilie Fedders Senior Media Relations Manager <a href="https://www.globenewswire.com/Tracker?data=5WMm1GPyn-MJQEalnLa3n9YY9ZzDsVKcJ0RPqxCZ7vd6BrYMO7AlPJ70qGHETb8sJZtfZBcPY2MBKf3gl5QAUKAi5LHwQwiA72OiQfeaWJ1IODF4cd-qrD1ZJfxjch3q">media-relations@novonesis.com</a>&nbsp; +45 30 77 71 82 Tobias Bjorklund Head of Investor Relations <a href="https://www.globenewswire.com/Tracker?data=ERdcg07WAKnCKEZGbJlIFI3aU0_Lsdnqzq2gPp9qlBdDtCVYAnAo5pLqG4Rg9W6FhFZwomLJUO6NVbzc93_DM1gtsT-E-DQhgt1ctR0PYrI=">tobb@novonesis.com</a>&nbsp; <img alt="" src="https://www.globenewswire.com/newsroom/ti?nf=MTAwMTE3MDMzMyM0MDIzNTg5NTIjMjAwMjM5NA=="> <img alt="" src="https://ml-eu.globenewswire.com/media/MDQ2ZWQ4MDItOWZhNS00YWYyLTgxYTMtYjZiZTJmYTBlMjMwLTEwMTM5NjctMjAyNi0wMy0xNi1lbg==/tiny/Novonesis-Novozymes-A-S-.png">

Novonesis issues EUR 1.7 billion in bonds to refinance bridge facility

Finansiella nyckeltal: EV/EBIT, EV/EBITA, EV/EBITDA och EV/Sales

Return on capital (ROE, ROI, ROIC, RONIC)

Finanslingo enkelt förklarat: EBIT, EBITA och EBITDA 

Intervjuer i samband med Stockholm Corporate Finance 17:e Kapitalmarknadsdagar Life Science 2026

Avkastning på kapital (ROE, ROI, ROIC, RONIC)